SCHEMBL18436331

SCHEMBL18436331

C[C@@H]1CN(c2ccccc2)C[C@@H](C)N1C(=O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.46
ACHE P22303 1/20 0.46
PLA2G1B P04054 1/20 0.45
ATG4B Q9Y4P1 1/20 0.45
HSD11B1 P28845 2/20 0.45
SLC6A7 Q99884 2/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
LMNA P02545 2/20 0.44
USP2 O75604 1/20 0.44
MAPT P10636 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19012397 0.91 SMO (0.46) POLBACHEPLA2G1BATG4BHSD11B1
SCHEMBL18436771 0.91 SMO (0.46) POLBACHEPLA2G1BATG4BHSD11B1
SCHEMBL19012460 0.91 SMO (0.46) POLBACHEPLA2G1BATG4BHSD11B1
SCHEMBL19000977 0.87 MEN1 (0.48) POLBHSD11B1ALDH1A1HPGDLMNA
SCHEMBL19000979 0.87 MEN1 (0.48) POLBHSD11B1ALDH1A1HPGDLMNA
SCHEMBL19001088 0.87 MEN1 (0.48) POLBHSD11B1ALDH1A1HPGDLMNA
SCHEMBL19012398 0.87 KDM4E (0.44) POLBACHEHSD11B1SLC6A7ALDH1A1
SCHEMBL19012400 0.87 SMO (0.44) ACHEPLA2G1BATG4BHSD11B1SLC6A7
SCHEMBL18436935 0.83 SMN1; SMN2 (0.47) POLBALDH1A1USP2MAPK1CYP3A4
SCHEMBL18435999 0.83 ACHE (0.49) POLBACHEPLA2G1BATG4BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3124482-A1 QUINOLINE DERIVATIVES AS SMO INHIBITORS GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2017-02-01 EP disclosed